Senior Research Scientist

Socket.dev

Indianapolis (IN)

Hybrid

USD 120,000 - 190,000

Full time

14 days+

Get more replies from employers

Send a job-specific resume in minutes.

Benefits offered by this job

Relocation packages
Shutdowns in US
8-week parental leave
Employee Resource Groups
Annual bonus
Flexible work arrangements
401K matching

Job summary

Elanco is seeking a Senior Research Scientist to lead target identification and validation across animal diseases, guiding cross-functional teams through early drug discovery. The role leverages in vitro techniques, AI/ML-driven platforms, and NAMs to accelerate Hit-to-Lead for small molecules and biologics.

Responsibilities include HTS-driven discovery, modeling translational biology with CRISPR-edited cells and organoids, and collaboration with CROs to push programs forward in a hybrid

Qualifications

  • Ph.D. in Cell/Molecular Biology, Pharmacology, Biochemistry, or related field with postdoc training.
  • Experience in industry research and early biotech/drug discovery incl. CRO management and digital discovery.
  • Expertise in NAMs (organoids, iPSCs) and AI/ML for target validation and phenotypic profiling.

Responsibilities

  • Lead target identification and discovery using in vitro/in vivo data, literature, bioinformatics, and AI/ML.
  • Design and deploy high-throughput, multi-modal screening strategies across assays.
  • Guide cross-functional teams through early discovery from concept to target validation.
  • Develop biomarker strategies and translational in vitro models, including CRISPR-edited cells and organoids.

Skills

Target identification
NAMs expertise
AI/ML validation

Education

Ph.D. in Cell/Molecular Biology or related

Tools

CRISPR screening
DNA-encoded library (DEL)

Job description

Your Role: Senior Research Scientist - Target Intelligence and Early Project Lead

As a Senior Scientist in the Mechanistic Biology team, you will lead novel target identification and validation across multiple animal diseases to build the drug discovery pipeline. This is a non-lab role focused on guiding cross-functional teams through early-stage drug discovery by leveraging advanced in vitro techniques, integrated AI/ML-driven platforms, and functional genomics. You will be responsible for accelerating the discovery cycle through high-throughput screening (HTS) approaches to rapidly move from Hit-to-Lead for both small molecules and biologics.

Your Responsibilities:
  • Target Identification & Discovery Innovation: Lead the identification and prioritization of novel targets using in vitro/in vivo experiments, literature reviews, bioinformatics, functional genomics, and AI/ML. Implement iterative design-test-learn and active learning cycles to optimize lead compounds and accelerate the discovery cycle.
  • Screening & Digital Discovery: Design and deploy high-throughput and multi-modal screening strategies—including biochemical, biophysical, and cellular approaches to identify novel chemical and biological starting points. Leverage AI-augmented data analysis, digital phenotyping, and digital discovery platforms to accelerate candidate identification and minimize experimental costs.
  • Cross-Functional Discovery Leadership: Guide cross-functional teams through early drug discovery from initial concept through target validation, partnering closely with Computational Sciences, Chemistry, Medicinal Chemistry, Computational Biology, Technical Development, and Preclinical Development. Collaborate with Computational Sciences to develop machine learning models for hit expansion and property prediction.
  • Target De-risking, Biomarkers & Translational Models: Develop strategies to de-risk targets and enhance commercial viability by integrating Chemistry, Manufacturing, and Controls (CMC) considerations and assessing on-target/off-target safety risks. Develop and integrate biological, AI-enabled, and imaging biomarker strategies and translational in vitro disease models, including CRISPR/Cas9-edited primary cell lines and organoids, to accelerate discovery.
  • External Partnerships & Scientific Advancement: Manage external CRO partnerships and biotech collaborations, providing scientific expertise to support discovery campaigns including DNA-encoded library (DEL), phage display, and yeast display. Foster strategic research collaborations and stay at the forefront of study design, model development, and New Approach Methodologies (NAMs) to maintain a competitive edge in animal health research.
What You Need to Succeed (minimum qualifications):
  • Education: Ph.D. in Cell/Molecular Biology, Pharmacology, Biochemistry, or a related field with several years of postdoctoral training.
  • Experience: Professional experience in industry research and early-stage biotech/drug discovery, including CRO management and experience with integrated digital discovery and HTS platforms.
  • Top 2 skills:Expert in target identification and validation: Including biological assay development for small/large molecules and expertise in high-throughput approaches to validate and identify targets (e.g., DEL, virtual screening).Expertise in New Approach Methodologies (NAMs): Such as organoids/iPSCs and CRISPR/Cas9 screening, with high proficiency in using AI/ML and deep learning for target validation and phenotypic profiling.
What will give you a competitive edge (preferred qualifications):
  • 3 years of experience in a pharmaceutical company, preferably in animal health.
  • Demonstrated success identifying novel targets and a proven publication record.
  • Experience with generative AI (e.g., ProteinMPNN) for de novo protein design and affinity maturation.
  • Demonstrated ability to lead projects in a fast-paced, agile environment; ability to collaborate and influence cross-functionally
  • Working knowledge of applicable statistical principles and data analysis techniques.
  • Experience with compound library screening and biomolecular training (RNA-seq, omics, flow cytometry).
Additional Information:
  • Travel: up to 25 %
  • Location: Global Elanco Headquarters - Indianapolis, IN - Hybrid Environment

Don’t meet every single requirement?Studies have shown underrepresented groups are less likely to apply to jobs unless they meet every single qualification. At Elanco we are dedicated to building a diverse and inclusive work environment. If you think you might be a good fit for a role but don't necessarily meet every requirement, we encourage you to apply. You may be the right candidate for this role or other roles!

Elanco Benefits and Perks:

We offer a comprehensive benefits package focusing on financial, physical, and mental well-being while encouraging our employees to pursue our purpose! Some highlights include:

  • Multiple relocation packages
  • Two weeklong shutdowns (mid-summer and year-end) in the US (in addition to PTO)
  • 8-week parental leave
  • 9 Employee Resource Groups
  • Annual bonus offering
  • Flexible work arrangements
  • Up to 6% 401K matching

Elanco is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

Elanco may use automated tools, including AI, to support parts of our recruitment process, such as reviewing applications against job-related criteria and/or transferrable skills. These tools help ensure a consistent, structured evaluation, but they do not make hiring decisions. All decisions involve a human reviewer. For more information on how we handle personal data, please see our Elanco Workforce Privacy Notice.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Senior Research Scientist
Senior Research Scientist

Elanco in • Indianapolis (IN)

On-site
USD 120,000 - 170,000
Relocation packages
Shutdowns
Parental leave
+3
Senior Research Scientist
Senior Research Scientist

Elanco Tiergesundheit AG • Indianapolis (IN), Northern (KY)

Hybrid
USD 120,000 - 190,000
Relocation packages
Two weeklong shutdowns (US)
8-week parental leave
+4
Senior Research Scientist
Senior Research Scientist

Elanco • Indianapolis (IN)

Hybrid
USD 110,000 - 170,000
Principal Scientist, External Innovation – Infectious Disease & Vaccines.
Principal Scientist, External Innovation – Infectious Disease & Vaccines.

Elanco • Indianapolis (IN)

On-site
USD 140,000 - 180,000
Relocation packages
Two weeklong shutdowns (mid-summer and
year-end) in the US (in addition to)
+5
Senior Associate Scientist – Plate-Based Analytical Assays – Transitional and Early Development
Senior Associate Scientist – Plate-Based Analytical Assays – Transitional and Early Development

Socket.dev • Indianapolis (IN)

Hybrid
USD 90,000 - 120,000
Relocation packages
Two weeklong shutdowns (US)
8‑week parental leave
+4
Senior Associate Scientist – Plate-Based Analytical Assays – Transitional and Early Development
Senior Associate Scientist – Plate-Based Analytical Assays – Transitional and Early Development

Elanco • Indianapolis (IN)

Hybrid
USD 70,000 - 100,000
Relocation packages
Two weeklong shutdowns
8 weeks parental leave
+3
Senior Research Scientist - Medicinal Chemist
Senior Research Scientist - Medicinal Chemist

Elanco Tiergesundheit AG • Indianapolis (IN), Northern (KY)

Hybrid
USD 120,000 - 190,000
Relocation packages
Two weeklong shutdowns
8-week parental leave
+3
Research Scientist - Computational Biologist
Research Scientist - Computational Biologist

Elanco • Indianapolis (IN)

Hybrid
USD 90,000 - 150,000
Relocation packages
2 weeklong shutdowns (US)
8‑week parental leave
+4
Senior Research Scientist- Internal Medicine Physiologist and Early Project Lead
Senior Research Scientist- Internal Medicine Physiologist and Early Project Lead

Elanco in • Indianapolis (IN)

Hybrid
USD 142,000 - 174,000
Relocation packages
PTO and holidays
Parental leave
+1
Senior Research Scientist - Medicinal Chemist
Senior Research Scientist - Medicinal Chemist

Elanco in • Indianapolis (IN)

Hybrid
USD 142,000 - 174,000
Relocation packages
Hybrid work environment
Annual bonus
+1